2023 Miracles for Myeloma 5K Run/Walk Read more about 2023 Miracles for Myeloma 5K Run/Walk Add new comment
Sarclisa (isatuximab-irfc) Meets Primary Endpoint in Phase III IMROZ Trial Read more about Sarclisa (isatuximab-irfc) Meets Primary Endpoint in Phase III IMROZ TrialAdd new comment
European Commission Approves ELREXFIO (elranatamab-bcmm) for Relapsed/Refractory Multiple Myeloma Read more about European Commission Approves ELREXFIO (elranatamab-bcmm) for Relapsed/Refractory Multiple Myeloma Add new comment
IMF Medical Student Scholar for Health Equity in Myeloma Semaje Testamark Receives Prestigious 2023 ASH Abstract Achievement Award Read more about IMF Medical Student Scholar for Health Equity in Myeloma Semaje Testamark Receives Prestigious 2023 ASH Abstract Achievement AwardAdd new comment
NLB Members Convene for the 19th Meeting of Impact and Innovation Read more about NLB Members Convene for the 19th Meeting of Impact and Innovation Add new comment
The Mayo Clinic’s PragMMatic Study Is Now Accruing Newly Diagnosed Multiple Myeloma Patients Read more about The Mayo Clinic’s PragMMatic Study Is Now Accruing Newly Diagnosed Multiple Myeloma PatientsAdd new comment
GSK Announces Positive Results in a Phase III Trial of Blenrep Read more about GSK Announces Positive Results in a Phase III Trial of Blenrep Add new comment
November 2023 – Myeloma News from the Journals Read more about November 2023 – Myeloma News from the JournalsAdd new comment
